These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 21172032)

  • 1. Whole-exome sequencing for finding de novo mutations in sporadic mental retardation.
    Robinson PN
    Genome Biol; 2010; 11(12):144. PubMed ID: 21172032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A de novo paradigm for mental retardation.
    Vissers LE; de Ligt J; Gilissen C; Janssen I; Steehouwer M; de Vries P; van Lier B; Arts P; Wieskamp N; del Rosario M; van Bon BW; Hoischen A; de Vries BB; Brunner HG; Veltman JA
    Nat Genet; 2010 Dec; 42(12):1109-12. PubMed ID: 21076407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Range of genetic mutations associated with severe non-syndromic sporadic intellectual disability: an exome sequencing study.
    Rauch A; Wieczorek D; Graf E; Wieland T; Endele S; Schwarzmayr T; Albrecht B; Bartholdi D; Beygo J; Di Donato N; Dufke A; Cremer K; Hempel M; Horn D; Hoyer J; Joset P; Röpke A; Moog U; Riess A; Thiel CT; Tzschach A; Wiesener A; Wohlleber E; Zweier C; Ekici AB; Zink AM; Rump A; Meisinger C; Grallert H; Sticht H; Schenck A; Engels H; Rappold G; Schröck E; Wieacker P; Riess O; Meitinger T; Reis A; Strom TM
    Lancet; 2012 Nov; 380(9854):1674-82. PubMed ID: 23020937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-familial cases of intellectual disability could be linked to de novo genetic mutations: studies suggest the potential of exome sequencing to diagnose causes of severe cases.
    Am J Med Genet A; 2013 Jan; 161A(1):vii-viii. PubMed ID: 23281303
    [No Abstract]   [Full Text] [Related]  

  • 5. From the periphery to centre stage: de novo single nucleotide variants play a key role in human genetic disease.
    Ku CS; Tan EK; Cooper DN
    J Med Genet; 2013 Apr; 50(4):203-11. PubMed ID: 23396985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. De novo mutations in human genetic disease.
    Veltman JA; Brunner HG
    Nat Rev Genet; 2012 Jul; 13(8):565-75. PubMed ID: 22805709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic exome sequencing in persons with severe intellectual disability.
    de Ligt J; Willemsen MH; van Bon BW; Kleefstra T; Yntema HG; Kroes T; Vulto-van Silfhout AT; Koolen DA; de Vries P; Gilissen C; del Rosario M; Hoischen A; Scheffer H; de Vries BB; Brunner HG; Veltman JA; Vissers LE
    N Engl J Med; 2012 Nov; 367(20):1921-9. PubMed ID: 23033978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exome sequencing analysis in a pair of monozygotic twins re-evaluates the genetics behind their intellectual disability and reveals a CHD2 mutation.
    Pinto AM; Bianciardi L; Mencarelli MA; Imperatore V; Di Marco C; Furini S; Suppiej A; Salviati L; Tenconi R; Ariani F; Mari F; Renieri A
    Brain Dev; 2016 Jun; 38(6):590-6. PubMed ID: 26754451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Whole exome sequencing is necessary to clarify ID/DD cases with de novo copy number variants of uncertain significance: Two proof-of-concept examples.
    Giorgio E; Ciolfi A; Biamino E; Caputo V; Di Gregorio E; Belligni EF; Calcia A; Gaidolfi E; Bruselles A; Mancini C; Cavalieri S; Molinatto C; Cirillo Silengo M; Ferrero GB; Tartaglia M; Brusco A
    Am J Med Genet A; 2016 Jul; 170(7):1772-9. PubMed ID: 27108886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Study of
    Gao ZJ; Jiang Q; Chen XL; Chen Q; Ji XN; Mao YY; Feng S; Dong JJ; Xu KM
    Zhonghua Yi Xue Za Zhi; 2018 Nov; 98(42):3426-3432. PubMed ID: 30440138
    [No Abstract]   [Full Text] [Related]  

  • 11. Exome sequencing identifies a de novo SCN2A mutation in a patient with intractable seizures, severe intellectual disability, optic atrophy, muscular hypotonia, and brain abnormalities.
    Baasch AL; Hüning I; Gilissen C; Klepper J; Veltman JA; Gillessen-Kaesbach G; Hoischen A; Lohmann K
    Epilepsia; 2014 Apr; 55(4):e25-9. PubMed ID: 24579881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identity-by-descent filtering of exome sequence data identifies PIGV mutations in hyperphosphatasia mental retardation syndrome.
    Krawitz PM; Schweiger MR; Rödelsperger C; Marcelis C; Kölsch U; Meisel C; Stephani F; Kinoshita T; Murakami Y; Bauer S; Isau M; Fischer A; Dahl A; Kerick M; Hecht J; Köhler S; Jäger M; Grünhagen J; de Condor BJ; Doelken S; Brunner HG; Meinecke P; Passarge E; Thompson MD; Cole DE; Horn D; Roscioli T; Mundlos S; Robinson PN
    Nat Genet; 2010 Oct; 42(10):827-9. PubMed ID: 20802478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exome sequencing covers >98% of mutations identified on targeted next generation sequencing panels.
    LaDuca H; Farwell KD; Vuong H; Lu HM; Mu W; Shahmirzadi L; Tang S; Chen J; Bhide S; Chao EC
    PLoS One; 2017; 12(2):e0170843. PubMed ID: 28152038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a novel CTCF mutation responsible for syndromic intellectual disability - a case report.
    Bastaki F; Nair P; Mohamed M; Malik EM; Helmi M; Al-Ali MT; Hamzeh AR
    BMC Med Genet; 2017 Jun; 18(1):68. PubMed ID: 28619046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficient application of next-generation sequencing for the diagnosis of rare genetic syndromes.
    Madrigal I; Alvarez-Mora MI; Karlberg O; Rodríguez-Revenga L; Elurbe DM; Rabionet R; Mur A; Pie J; Ballesta F; Sauer S; Syvänen AC; Milà M
    J Clin Pathol; 2014 Dec; 67(12):1099-103. PubMed ID: 25271213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A de novo mutation in ZMYND11, a candidate gene for 10p15.3 deletion syndrome, is associated with syndromic intellectual disability.
    Cobben JM; Weiss MM; van Dijk FS; De Reuver R; de Kruiff C; Pondaag W; Hennekam RC; Yntema HG
    Eur J Med Genet; 2014; 57(11-12):636-8. PubMed ID: 25281490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A de novo mutation in FMR1 in a patient with intellectual disability.
    Maddirevula S; Alsaif HS; Ibrahim N; Alkuraya FS
    Eur J Med Genet; 2020 Mar; 63(3):103763. PubMed ID: 31518692
    [No Abstract]   [Full Text] [Related]  

  • 18. De novo mutations in FOXP1 in cases with intellectual disability, autism, and language impairment.
    Hamdan FF; Daoud H; Rochefort D; Piton A; Gauthier J; Langlois M; Foomani G; Dobrzeniecka S; Krebs MO; Joober R; Lafrenière RG; Lacaille JC; Mottron L; Drapeau P; Beauchamp MH; Phillips MS; Fombonne E; Rouleau GA; Michaud JL
    Am J Hum Genet; 2010 Nov; 87(5):671-8. PubMed ID: 20950788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Numerous BAF complex genes are mutated in Coffin-Siris syndrome.
    Miyake N; Tsurusaki Y; Matsumoto N
    Am J Med Genet C Semin Med Genet; 2014 Sep; 166C(3):257-61. PubMed ID: 25081545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterozygous de-novo mutations in ATP1A3 in patients with alternating hemiplegia of childhood: a whole-exome sequencing gene-identification study.
    Rosewich H; Thiele H; Ohlenbusch A; Maschke U; Altmüller J; Frommolt P; Zirn B; Ebinger F; Siemes H; Nürnberg P; Brockmann K; Gärtner J
    Lancet Neurol; 2012 Sep; 11(9):764-73. PubMed ID: 22850527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.